Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines
Open Access
- 25 March 2020
- journal article
- research article
- Published by China Anti-cancer Association in Cancer Biology & Medicine
- Vol. 17 (4) , 970-985
Abstract
Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell linesKeywords
This publication has 67 references indexed in Scilit:
- Chromosome instability and benefit from adjuvant anthracyclines in breast cancerBritish Journal of Cancer, 2012
- A study of Docetaxel-induced effects in MCF-7 cells by means of Raman microspectroscopyAnalytical and Bioanalytical Chemistry, 2012
- How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicineBritish Journal of Cancer, 2010
- The role of HER2 in cancer therapy and targeted drug deliveryJournal of Controlled Release, 2010
- ERα-negative and triple negative breast cancer: Molecular features and potential therapeutic approachesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Chromosomal instability determines taxane responseProceedings of the National Academy of Sciences, 2009
- Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant ChemotherapyJNCI: Journal of the National Cancer Institute, 2009
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001